Medici Brands Raises $250 Million in Series B Funding

Corporate Action
โดย PR Newswire·US·Read original
Summary · why it matters

Medici Brands, parent of David Protein and confectionery brand HallPass, announced a $250 million Series B financing co-led by Greenoaks and Valor Equity Partners, with participation from CEO Peter Rahal, ICONIQ, and Imaginary Ventures. The round follows David's $75 million Series A in 2025, and the company is on track to surpass $300 million in revenue in 2026, making it the fastest food company to reach that milestone. The new capital will accelerate expansion of HallPass, extend David into new formats, and support the launch of a third brand, Rowdy, later this year. Medici also owns Epogee, maker of the plant-based fat substitute EPG.

Impact on stocks 3

Consumer Staples▲ · 3 stocks

Off-coverage companies 9

Medici BrandsPrivate▲ Positive
Capitalrelevance

Medici Brands itself raised $250M Series B co-led by Greenoaks and Valor Equity Partners.

David ProteinPrivate▲ Positive
Capitalrelevance

David Protein's parent Medici raised $250M Series B, with capital to extend David into new formats.

Greenoaks Capital PartnersPrivate▲ Positive
Capitalrelevance

Greenoaks co-led Medici Brands' $250M Series B financing.

HallPassPrivate▲ Positive
Capitalrelevance

New capital will accelerate expansion of HallPass, Medici's confectionery brand.

Valor Equity PartnersPrivate▲ Positive
Capitalrelevance

Valor co-led Medici Brands' $250M Series B financing.

ICONIQPrivate▲ Positive
Capitalrelevance

ICONIQ participated in Medici Brands' $250M Series B round.

Imaginary VenturesPrivate▲ Positive
Capitalrelevance

Imaginary Ventures participated in Medici Brands' $250M Series B round.

EpogeePrivate▲ Positive
Capitalrelevance

Medici, owner of Epogee, closed a $250M Series B financing that funds its brands.

RowdyPrivate▲ Positive
Technologyrelevance

Medici will use the new capital to launch its third brand, Rowdy, later this year.

© 2026 MarketDXNews